Showing results (1721-1730 of 1,877) with videos related to
Sort By:
Pageof 188
European Journal of Haematology|October 8, 2014
Weekly rituximab consolidation following four cycles of R-CHOP induction chemotherapy in very elderly patients with diffuse large B-cell lymphoma: Consortium for improving survival of lymphoma study (CISL)Sung-Hoon Jung, Je-Jung Lee, Won Seog Kim, et al.International Journal of Hematology|March 20, 2025
Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myelomaSoo Chin Ng, Joon-Ho Moon, Sung Soo Park, et al.Clinical and Translational Allergy|October 25, 2021
Prenatal PM2.5 affects atopic dermatitis depending on maternal anxiety and gender: COCOA studySangrok Kim, Song-I Yang, Hyeyeun Lim, et al.Oncology Reports|May 12, 2018
Protein arginine methyltransferase 5 is implicated in the aggressiveness of human hepatocellular carcinoma and controls the invasive activity of cancer cellsJu-Yeon Jeon, Jee San Lee, Eun-Ran Park, et al.American Journal of Hematology|June 15, 2007
Consideration of aggressive therapeutic strategies for primary testicular lymphomaByeong-Bae Park, Jong Gwang Kim, Sang Kyun Sohn, et al.Leukemia Research|July 23, 2013
Hepatic sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation in adult patients with idiopathic aplastic anemiaHawk Kim, Kyoo-Hyung Lee, Sang Kyun Sohn, et al.Cancer Research and Treatment|April 5, 2022
Busulfan, Melphalan, and Etoposide (BuME) Showed an Equivalent Effect to Busulfan, Cyclophosphamide, and Etoposide (BuCE) as Conditioning Therapy for Autologous Stem Cell Transplantation in Patients with Relapsed or High-Risk Non-Hodgkin's Lymphoma: A Multicenter Randomized Phase II Study bythe Consortium for Improving Survival of Lymphoma (CISL)Kyoung Ha Kim, Jae Hoon Lee, Mark Lee, et al.Annals of Hematology|August 4, 2018
Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohortsDong Won Baek, Yoo Jin Lee, Hyunjeong Kim, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 10, 2020
Glucosylceramide synthase regulates adipo-osteogenic differentiation through synergistic activation of PPARγ with GlcCerHyun-Jun Jang, Seyoung Lim, Jung-Min Kim, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 22, 2025
Efficacy and Safety of Capivasertib (AZD5363), a Potent, Oral Pan-AKT Inhibitor, in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (CAPITAL)Daniel J Hodson, Geoffrey Shouse, Ho-Jin Shin, et al.Pageof 188